Affordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life

JAMA Oncol. 2017 Oct 1;3(10):1301-1302. doi: 10.1001/jamaoncol.2017.0479.

Authors

Yehoda M Martei¹, Agnes Binagwaho^{2

3}, Lawrence N Shulman⁴

Affiliations

¹ Division of Hematology-Oncology, University of Pennsylvania, Philadelphia.
² University of Global Health Equity, Kigali, Rwanda.
³ Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
⁴ Abramson Cancer Center, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia.

PMID: 28426846
DOI: 10.1001/jamaoncol.2017.0479

No abstract available

MeSH terms

Africa South of the Sahara / epidemiology
Antineoplastic Agents / economics*
Biosimilar Pharmaceuticals / economics
Costs and Cost Analysis / economics*
Drug Costs
Health Services Accessibility
Humans
Neoplasms / drug therapy
Neoplasms / mortality*
Socioeconomic Factors

Substances

Antineoplastic Agents
Biosimilar Pharmaceuticals